Document is current

Any future updates will be listed below

Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy

Crossref DOI link: https://doi.org/10.1186/s12974-017-0818-5

Published Online: 2017-03-20

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark